Long-term survival in unfavourable-risk mRCC patients after intratumoral administration of a cell-based allogeneic vaccine
Crossref DOI link: https://doi.org/10.1186/2051-1426-3-S2-P438
Published Online: 2015-11-04
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Karlsson-Parra, Alex
Laurell, Anna
Lönnemark, Maria
Brekkan, Einar
Wallgren, AnnaCarin
Magnusson, Anders
Article History
First Online: 4 November 2015